<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39465757</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>40</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Association between PaO2/(FiO2*PEEP) ratio and in-hospital mortality in COVID-19 patients: A reanalysis of published data from Peru using PaO2/(FiO2*PEEP) ratio in place of PaO2/FaO2 ratio.</ArticleTitle><Pagination><StartPage>e39931</StartPage><MedlinePgn>e39931</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e39931</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000039931</ELocationID><Abstract><AbstractText>P/FP [PaO2/(FiO2*PEEP)] is associated with in-hospital mortality in patients with acute respiratory distress syndrome (ARDS). However, to the best of our knowledge, the association between P/FP after 24 hours of invasive mechanical ventilation (IMV) and in-hospital mortality in patients with ARDS due to Coronavirus Disease 2019 (COVID-19) remained unclear. This study aimed to evaluate the relationship between the P/FP after 24 hours of IMV and in-hospital mortality in patients with ARDS due to COVID-19. We reanalyzed previously published data from Peru. Hueda-Zavaleta et al conducted a retrospective cohort study between April 2020 and April 2021 in southern Peru. A total of 200 hospitalized COVID-19 patients requiring IMV were included in this analysis. We used Cox proportional hazard regression models and Kaplan-Meier survival analysis to investigate the effect of P/FP after 24 hours of IMV on in-hospital mortality. We used a restricted cubic spline regression and a two-piecewise Cox proportional hazards model to explore the relationship between P/FP after 24 hours of IMV and in-hospital mortality in patients with ARDS due to COVID-19. Of the 200 patients, 51 (25.50%) died in hospital. The median P/FP was 20.45 mm Hg/cmH2O [interquartile range 15.79-25.21 mm Hg/cmH2O], with a range of 5.67 mm Hg/cmH2O to 51.21 mm Hg/cmH2O. Based on the P/FP ratio, patients were equally divided into 2 groups (low group [P/FP &lt; 20.50 mm Hg/cmH2O] and high group [P/FP ≥ 20.50 mm Hg/cmH2O]). In-hospital mortality was lower in the high P/FP group than in the low P/FP group (12 [12%] vs 39 [39%]; unadjusted hazard ratio [HR]: 0.33, 95% confidence interval [CI]: 0.17-0.63; adjusted HR: 0.10, 95% CI: 0.02-0.47). We also found a nonlinear relationship between P/FP and in-hospital mortality. After adjusting for potential confounders, the HR was 0.67 (95% CI: 0.56-0.79) for P/FP ≤ 22 mm Hg/cmH2O and 1.10 (95% CI: 0.83-1.47) for P/FP &gt; 22 mm Hg/cmH2O. In addition, lymphocytes ≤ 1 × 109/L and acute kidney failure had a higher risk of death. After adjusting for potential confounders, the P/FP after 24 hours of IMV was nonlinearly associated with in-hospital mortality in patients with ARDS due to COVID-19.</AbstractText><CopyrightInformation>Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Youli</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Fujian Medical University Affiliated First Quanzhou Hospital, Quanzhou, Fujian, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Huangen</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jinhuang</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Zhiwei</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Tianlai</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010568" MajorTopicYN="N" Type="Geographic">Peru</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001784" MajorTopicYN="N">Blood Gas Analysis</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>8</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39465757</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000039931</ArticleId><ArticleId IdType="pii">00005792-202410040-00066</ArticleId><ArticleId IdType="pmc">PMC11460852</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ranieri VM, Rubenfeld GD, Thompson BT, et al. . Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526–33.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA. 2018;319:698–710.</Citation><ArticleIdList><ArticleId IdType="pubmed">29466596</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Lim WS, Emberson JR, et al. . Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693–704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordon J, Akca O, Furmanek S, et al. . Acute respiratory distress syndrome and time to weaning off the invasive mechanical ventilator among patients with COVID-19 Pneumonia. J Clin Med. 2021;10:2935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8269065</ArticleId><ArticleId IdType="pubmed">34208922</ArticleId></ArticleIdList></Reference><Reference><Citation>Taenaka H, Yoshida T, Hashimoto H, et al. . Individualized ventilatory management in patients with COVID-19-associated acute respiratory distress syndrome. Respir Med Case Rep. 2021;33:101433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8165976</ArticleId><ArticleId IdType="pubmed">34094847</ArticleId></ArticleIdList></Reference><Reference><Citation>Hueda-Zavaleta M, Copaja-Corzo C, Miranda-Chávez B, et al. . Determination of PaO2/FiO2 after 24 h of invasive mechanical ventilation and ΔPaO2/FiO2 at 24 h as predictors of survival in patients diagnosed with ARDS due to COVID-19. PeerJ. 2022;10:e14290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9756861</ArticleId><ArticleId IdType="pubmed">36530414</ArticleId></ArticleIdList></Reference><Reference><Citation>Palanidurai S, Phua J, Chan YH, Mukhopadhyay A. P/FP ratio: incorporation of PEEP into the PaO2/FiO2 ratio for prognostication and classification of acute respiratory distress syndrome. Ann Intensive Care. 2021;11:124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8350287</ArticleId><ArticleId IdType="pubmed">34370116</ArticleId></ArticleIdList></Reference><Reference><Citation>Izcovich A, Ragusa MA, Tortosa F, et al. . Prognostic factors for severity and mortality in patients infected with COVID-19: a systematic review. PLoS One. 2020;15:e0241955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7671522</ArticleId><ArticleId IdType="pubmed">33201896</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildirim M, Halacli B, Pektezel MY, et al. . Comparison of critically ill COVID-19 and influenza patients with acute respiratory failure. Acute Crit Care. 2022;37:168–76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9184989</ArticleId><ArticleId IdType="pubmed">35280038</ArticleId></ArticleIdList></Reference><Reference><Citation>de Fraga Gomes Martins L, da Silva Naue W, Skueresky AS, Bianchi T, Dias AS, Forgiarini LA. Effects of combined tracheal suctioning and expiratory pause: a crossover randomized clinical trial. Indian J Crit Care Med. 2019;23:454–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6842827</ArticleId><ArticleId IdType="pubmed">31749553</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiumello D, Bonifazi M, Pozzi T, et al. . Positive end-expiratory pressure in COVID-19 acute respiratory distress syndrome: the heterogeneous effects. Crit Care. 2021;25:431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674862</ArticleId><ArticleId IdType="pubmed">34915911</ArticleId></ArticleIdList></Reference><Reference><Citation>Robba C, Battaglini D, Ball L, et al. . Distinct phenotypes require distinct respiratory management strategies in severe COVID-19. Respir Physiol Neurobiol. 2020;279:103455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211757</ArticleId><ArticleId IdType="pubmed">32437877</ArticleId></ArticleIdList></Reference><Reference><Citation>Battaglini D, Sottano M, Ball L, Robba C, Rocco PRM, Pelosi P. Ten golden rules for individualized mechanical ventilation in acute respiratory distress syndrome. J Intensive Med. 2021;1:42–51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919509</ArticleId><ArticleId IdType="pubmed">36943812</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Forni LG, Klein SJ, et al. . Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup. Intensive Care Med. 2020;46:654–72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7103017</ArticleId><ArticleId IdType="pubmed">31820034</ArticleId></ArticleIdList></Reference><Reference><Citation>Cut TG, Mavrea A, Cumpanas AA, et al. . A retrospective assessment of sputum samples and antimicrobial resistance in COVID-19 Patients. Pathogens. 2023;12:620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10143659</ArticleId><ArticleId IdType="pubmed">37111506</ArticleId></ArticleIdList></Reference><Reference><Citation>Arentz M, Yim E, Klaff L, et al. . Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020;323:1612–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7082763</ArticleId><ArticleId IdType="pubmed">32191259</ArticleId></ArticleIdList></Reference><Reference><Citation>Payán-Pernía S, Gómez Pérez L, Remacha Sevilla AF, Sierra Gil J, Novelli Canales S. Absolute lymphocytes, ferritin, c-reactive protein, and lactate dehydrogenase predict early invasive ventilation in patients With COVID-19. Lab. Med. 2021;52:141–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7798986</ArticleId><ArticleId IdType="pubmed">33336243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuiper JW, Groeneveld AB, Slutsky AS, Plötz FB. Mechanical ventilation and acute renal failure. Crit Care Med. 2005;33:1408–15.</Citation><ArticleIdList><ArticleId IdType="pubmed">15942363</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Akker JP, Egal M, Groeneveld AB. Invasive mechanical ventilation as a risk factor for acute kidney injury in the critically ill: a systematic review and meta-analysis. Crit Care. 2013;17:R98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3706893</ArticleId><ArticleId IdType="pubmed">23710662</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46:1339–48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7290076</ArticleId><ArticleId IdType="pubmed">32533197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottolina D, Zazzeron L, Trevisi L, et al. . Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP). J Nephrol. 2022;35:99–111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226340</ArticleId><ArticleId IdType="pubmed">34170508</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>